ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Drug developer BenevolentAI enters SPAC merger deal with Odyssey Pharmaceutical-Technology
December 08, 2021UK-based clinical-stage artificial intelligence (AI) drug discovery firm BenevolentAI has signed a definitive agreement for a business combination with the special-purpose acquisition company (SPAC) Odyssey Acquisition.
Pharma Sources Insight July 2025
